IMRN
Price:
$1.61
Market Cap:
$14.96M
Immuron Limited, a biopharmaceutical company, researches, develops, and commercializes polyclonal antibodies in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It markets Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and reduce the symptoms of minor gastro-intestinal disorders, as well as for dietary supplement for digestive tract protection; and Protectyn, an immune supplement to maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) that is in Phase III clinical trials to reduce the risk of contracting travelers' d...[Read more]
Industry
Biotechnology
IPO Date
2017-06-09
Stock Exchange
NASDAQ
Ticker
IMRN
According to Immuron Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.94. This represents a change of 6.86% compared to the average of -1.82 of the last 4 quarters.
The mean historical PE Ratio of Immuron Limited over the last ten years is -6.57. The current -1.94 PE Ratio has changed 2.85% with respect to the historical average. Over the past ten years (40 quarters), IMRN's PE Ratio was at its highest in in the June 2013 quarter at -0.20. The PE Ratio was at its lowest in in the June 2005 quarter at -13.58.
Average
-6.57
Median
-4.37
Minimum
-15.67
Maximum
-2.70
Discovering the peaks and valleys of Immuron Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 303.23%
Maximum Annual PE Ratio = -2.70
Minimum Annual Increase = -74.26%
Minimum Annual PE Ratio = -15.67
Year | PE Ratio | Change |
---|---|---|
2024 | -2.73 | -39.58% |
2023 | -4.51 | -28.37% |
2022 | -6.30 | 49.32% |
2021 | -4.22 | -73.07% |
2020 | -15.67 | 303.23% |
2019 | -3.89 | -74.26% |
2018 | -15.09 | 259.28% |
2017 | -4.20 | 55.40% |
2016 | -2.70 | -57.40% |
2015 | -6.35 | 90.38% |
The current PE Ratio of Immuron Limited (IMRN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.51
5-year avg
-6.68
10-year avg
-6.57
Immuron Limited’s PE Ratio is less than TScan Therapeutics, Inc. (-1.19), greater than VectivBio Holding AG (-7.94), less than IN8bio, Inc. (-0.40), greater than Phio Pharmaceuticals Corp. (-11.65), greater than Immix Biopharma, Inc. (-3.00), less than Sio Gene Therapies Inc. (0), less than Magenta Therapeutics, Inc. (-0.49), less than TRACON Pharmaceuticals, Inc. (-0.02), less than ARCA biopharma, Inc. (0), less than Innate Pharma S.A. (-0.02), greater than Addex Therapeutics Ltd (-46.73), greater than Aptorum Group Limited (-3.22), less than Celyad Oncology SA (0.79), less than Dyadic International, Inc. (259.24), greater than null (-3.06), greater than null (-5.44),
Company | PE Ratio | Market cap |
---|---|---|
-1.19 | $68.47M | |
-7.94 | $1.06B | |
-0.40 | $11.80M | |
-11.65 | $8.78M | |
-3.00 | $58.82M | |
0 | $0 | |
-0.49 | $42.44M | |
-0.02 | $109.72K | |
0 | $34.82M | |
-0.02 | $195.37M | |
-46.73 | $6.97M | |
-3.22 | $6.47M | |
0.79 | $14.24M | |
259.24 | $31.90M | |
-3.06 | $0 | |
-5.44 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immuron Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immuron Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Immuron Limited's PE Ratio?
How is the PE Ratio calculated for Immuron Limited (IMRN)?
What is the highest PE Ratio for Immuron Limited (IMRN)?
What is the 3-year average PE Ratio for Immuron Limited (IMRN)?
What is the 5-year average PE Ratio for Immuron Limited (IMRN)?
How does the current PE Ratio for Immuron Limited (IMRN) compare to its historical average?